View Nova Biomedical’s product lines ranging from hospital point-of-care measuring systems and hospital blood gas analyzers to biotech chemistry/cell analyzers and self-testing diabetes monitoring systems.
Webinars on timely topics such as POCT, critical care, clinical practice and regulatory updates, and common conditions including sepsis and hyperglycemia.
About Nova Biomedical
Incorporated in 1976 and based in Waltham, MA, Nova Biomedical is a world leader in the development and manufacturing of state-of-the-art, whole blood, point-of-care and critical care analyzers, as well as providing the biotechnology industry with the most advanced instruments for cell culture monitoring. Nova is one of the fastest growing in vitro diagnostic companies in the world. Nova’s biosensor technology is incorporated in products ranging from handheld meters for glucose self- and point-of-care testing to critical care whole blood analyzers designed for rapid measurement of over 20 analytes. Nova’s biotechnology-specific BioProfile line has pioneered comprehensive cell culture testing, providing over 20 critical cell culture tests with over 12 unique instrument offerings for broad range of cell culture applications. Nova employs over 1,200 people worldwide and has wholly owned subsidiaries located in Brazil, Canada, Great Britain, Spain, France, Switzerland, Germany, Italy, Japan, and Taiwan. Certified by the International Organization for Standardization, Nova has manufacturing operations located in the U.S., Taiwan, and Brazil.
Nova Biomedical is pleased to announce the latest addition to the StatStrip line of handheld, hospital meters with the StatStrip Hemoglobin and Hematocrit Meter System (StatStrip Hb/Hct), which has gained CE mark certification and is now available in all CE regulated countries. ... Details
Every month, MassBio spotlights a member company and the great work they're doing to advance the life sciences industry and support the patients we serve. This month we spoke with Nick Theodore, Senior Vice President of Global Sales and Marketing for Nova Biomedical. ... Details
Nova Biomedical Launches New Veterinary Critical Care Analyzer Stat Profile Prime Plus VET : New technologies improve testing, animal care, and profitability
Nova Biomedical is pleased to announce the domestic and international launch of Stat Profile Prime Plus VET, the latest addition to the Stat Profile line of veterinary critical care analyzers. Prime Plus VET is the most comprehensive veterinary critical care analyzer, offering 22 critical care tests including regulated countries... Details